<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
>
<channel>
	<title><![CDATA[Fowler Gyn International Blog]]></title>
	<atom:link href="https://www.fowlergyninternational.com/blog/category/vaginal-estrogen/feed/" rel="self" type="application/rss+xml" />
	<link><![CDATA[https://www.fowlergyninternational.com/blog/]]></link>
	<description><![CDATA[Fowler Gyn International Blog]]></description>
	<lastBuildDate>Sun, 17 May 2026 05:38:19 +0000</lastBuildDate>
	<language></language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator><![CDATA[http://fishpig.co.uk/wordpress-integration/]]></generator>
			<item>
		<title><![CDATA[New Study Supports that the Use of Vaginal Estrogen is Safe in Women with a History of Breast Cancer]]></title>
		<link><![CDATA[https://www.fowlergyninternational.com/blog/new-study-supports-that-the-use-of-vaginal-estrogen-is-safe-in-women-with-a-history-of-breast-cancer/]]></link>
		<comments><![CDATA[https://www.fowlergyninternational.com/blog/new-study-supports-that-the-use-of-vaginal-estrogen-is-safe-in-women-with-a-history-of-breast-cancer/#respond]]></comments>
		<pubDate>Wed, 21 Feb 2024 15:44:29 +0000</pubDate>
		<dc:creator>turboadmin</dc:creator>
			<guid isPermaLink="false"><![CDATA[https://www.fowlergyninternational.com/blog/?p=220]]></guid>
			<description><![CDATA[The Journal of Obstetrics and Gynecology published a study in September 2023 that investigated whether treating with vaginal estrogen for vulvovaginal symptoms of menopause posed a safety risk to breast cancer survivors, particularly the risk of breast cancer recurrence. The conclusion, that they found NO increase in risk and therefore the use of vaginal estrogen appears to be safe in breast cancer survivors, regardless of whether they had estrogen receptor positive (ER+) versus estrogen receptor negative (ER-) breast cancer.1
In the United States, breast cancer is the #2 cancer affecting women and will likely affect 1 in 8 women within their...]]></description>
			</item>
	</channel>
</rss>